Form 4: Vertex Pharmaceuticals EVP and CMO, Carmen Bozic, Reports Stock Disposal
SEC Form 4 Filing
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals, reported disposing of 1,912 shares of common stock on February 14, 2025.
Summary
- On February 14, 2025, Carmen Bozic, the EVP and CMO of Vertex Pharmaceuticals, disposed of 1,912 shares of common stock.
- The transaction was executed at a price of $463.46 per share.
- Following the transaction, Bozic directly owns 40,941 shares of Vertex Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it is a standard disclosure of stock transactions by an executive. There is no inherent positive or negative implication.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company executives.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as it provides information about insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 02/14/2025 | Date of the stock disposal transaction |
| 02/19/2025 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.